Zolmax Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) - Analysts at Zacks Research raised their Q4 2025 earnings per share (EPS) estimates for shares of Thermo Fisher Scientific in a note issued...\n more…
Zolmax First Foundation Advisors trimmed its stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 10.4% during the second quarter, according to its most recent 13F filing with the SEC. The...\n more…
Ticker Report Oak Thistle LLC increased its position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 6.3% in the 2nd quarter, HoldingsChannel reports. The fund owned 588 shares of the medical research...\n more…
Zolmax Koss Olinger Consulting LLC purchased a new position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 531 shares of the...\n more…
Ticker Report Koss Olinger Consulting LLC purchased a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the second quarter, according to its most recent filing with the SEC. The...\n more…